Skip to content
Clinical Trials – home
Upstream Bio Inc.
Sponsor

Upstream Bio Inc.

United States 890 Winter Street Suite 200, 02451-1490, United States

About the sponsor

Clinical research in chronic rhinosinusitis with nasal polyps centers on improving control of nasal polyps and related upper-airway inflammation, with attention to symptom burden and endoscopic outcomes.

  • Endoscopic nasal polyp score
  • Nasal corticosteroid background therapy
  • Upper airway inflammation

The sponsor is active in respiratory and inflammatory disease research with a focus on conditions affecting the nasal and sinus passages.

About Specializations

Upstream Bio Inc. runs clinical trials in conditions such as Asthmatic crisis, Chronic obstructive pulmonary disease, Chronic rhinosinusitis with nasal polyps, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Asthmatic crisis

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.